birth control pulmonary embolism

Birth Control Induced Pulmonary Emboli: Sudden and Slow

8744 views

Pulmonary emboli are notoriously difficult to diagnose clinically, especially in otherwise healthy young women. The early signs include such nondescript symptoms as breathing difficulties, chest or back pain, and fatigue; symptoms that are easily attributable to a host of viral and bacterial infections or other less serious respiratory conditions. As a result, and more often than not, it is not until complete hemodynamic collapse that PE is considered; a point at which survival is significantly less likely. Even then, for young women the prospect of pulmonary emboli is not always on the differential. We saw this repeatedly in our pilot study, the Real Risk Birth Control and Blood Clots study where the prospect of birth control induced blood clots was rarely considered. From a review of records and case stories, blood clots seemed only to be considered after everything else was ruled out. That is, they were near the bottom, if not absolutely last, on the diagnostic differential. When the emboli were in the lungs, this refusal to consider contraceptive induced hyper-coagulation has deadly consequences.

When we consider that the most commonly recognized risk associated with hormonal birth control are blood clots, one cannot help but wonder why birth control-induced blood clots are not automatically ruled out when women present to the ER in crisis, but they are not. Time and time again, the early signs of an imminent crisis were dismissed by healthcare practitioners. Neither the deep vein thrombi that frequently preceded the pulmonary emboli by as much as a month, nor the pulmonary emboli were immediately recognized. And as we reported previously, recognition was equally labored in women who developed cerebral venous thrombi, brain clots, often requiring 2-3 ER visits before the diagnosis is even considered. I am not sure why there is such a total break down in clinical acuity when it comes to birth control-induced blood clots, but by all accounts, there is.

Perhaps our familiarity with these drugs has bred a false sense of safety; one so firmly entrenched that even when faced with evidence to the contrary, when life or death hang in balance, we cannot bring ourselves to acknowledge their risks. Perhaps so strong is our desire and need to have effective birth control options, that we employ a sort of willful ignorance about the risks. Or more cynically, perhaps we have simply been duped by Madmen inspired, pharmaceutical funded half-truths and platitudes.

Whatever the reasons, the patient reports suggest that when confronted with evidence of blood clots, all involved tend to dismiss the possibility until all other causes are ruled out. Physicians especially seem reticent to consider blood clots, forgetting entirely that hormonal birth control hyperactivates blood coagulation cascades in favor of clotting – in all women, not just some women, but in all women. They increase pro-clotting factors by 170% and decrease anti-clotting factors by 20%, a change in hemodynamics that all but guarantees a propensity toward body-wide clotting, especially when other health or lifestyle variables are present. No matter the chemistry, however, when clots happen, we all seem genuinely surprised. If the results of this study show anything, it is that birth control induced blood clots are real and should be ruled out first, not last.

Sudden and Slow: The Two Faces of Pulmonary Emboli

One of the key goals of the Real Risk Birth Control Blood Clots study is to identify early warning signs of clotting. To that end, the women who took the survey were asked to identify the presence and severity of 35 symptoms commonly attributed to blood clots, at a month out, a week out, the day before, and the day of, the crisis. Although we found significant linear trends in the escalating severity of many symptoms across time for the group as a whole, more telling were the patterns that emerged when we divided the groups by diagnosis (DVT,  DVT + PE, stroke, etc.). There we see distinct patterns in the type of symptoms as well as the trajectory of expression and severity.

For example, when we look at the patterns of early warning signs of pulmonary emboli, we see two, possibly three, trends emerging. In some women, pulmonary emboli seem to appear suddenly with few if any warning signs. In other women, symptoms either increased over time or waxed and waned (or both), sometimes for months, until reaching an apex of severity. For the latter group, the waxing and waning seemed related to the movement of the clot(s) from the periphery to the lungs. That is, the localized pain, swelling, and temperature changes, either in the legs, pelvis, abdomen, or collarbone regions, would be severe for a week or a month before the event and then dissipate entirely, only to re-emerge as the crushing pain associated with the pulmonary embolism. We will be reporting more details in subsequent articles, but preliminarily, the data and the personal accounts suggest the possibility that PEs may be preventable, if the signs of deep vein thrombosis (DVT) are more readily recognized.

Listed below are descriptions of the events leading up to the crisis reported by women with pulmonary emboli who completed Phase 1 of the Real Risk Birth Control and Blood Clot survey. A similar report was published for women who survived strokes.

Sudden Onset

“my chest hurt to the point I could not lay down or move without excruciating pain” – during the crisis – no symptoms prior.

CS2 reports severe right thigh pain the day of the crisis, as well as moderate chest pain, shortness of breath and fatigue and mild back pain, but nothing before that point. The PE caused low blood pressure. Doctors were unable to detect blood pressure in her right arm.

JR began to experience mild discomfort the day before her crisis. The day of her crisis, she explains, “the symptoms [severe shortness of breath, chest pain, irregular heartbeat, dizziness, blackouts, fatigue, and mild to moderate headache, nausea, difficulty speaking, and stomach pain] worsened as the day went on.” She goes on to say that “right before I passed out and then once when I woke up, it was crushing burning pain and my heart was beating so fast that I couldn’t catch my breath.”

RF’s clots originated in the pelvis and legs and experienced severe pain and swelling in the pelvis the day before her crisis.

Tales of Traveling DVTs

“…right lower calf was swollen and warm to the touch, pain felt like a Charley horse. Chest pain was unbearable. It hurt to breathe and my heart was racing so fast that it hurt.” – per her data, leg pain developed a week before but disappeared; chest and heart pain appeared the day of the crisis; fatigue was moderate to severe from week before.

Twenty year old CS  reported moderate to severe right shoulder and chest pain a month before the crisis, along with moderate fatigue from a week out. The day of the crisis, the pain moved to lower chest. She describes the chest pain as: “Every time I took a breath in it felt like a knife was being stabbed into my chest on the right side.” Like so many others, she was sent home from doctor’s office day of crisis only to return to ER that night to discover her right lung was riddled with clots, necrotic in places.

KM had very few symptoms leading up to her PE, except a “sharp pain deep in my calf – I thought I had a badly pulled muscle or strain my Achilles tendon (up high) while jogging. The pain got much worse if I was standing for long periods of time, but got much better if I exercised.” She also reports shortness of breath climbing stairs or when giving a presentation.

ES described her symptoms: “leg pain felt like a bad cramp, almost as the back of the leg had seized up. I thought it was a pulled muscle because I lacked other symptoms. The PE pain was a crushing, hot pain in my chest, worse when breathing in.” Her leg pain began a month prior to the PE, peaked a week before and then dissipated entirely. While the pain from the PE began a week prior to the crisis and escalated.

FH rates all of the symptoms leading up to the crisis as mild, even though some of the symptoms emerged months before. She chalked up her leg pain to occasional muscle cramps and the shortness of breath to sinus issues.  It wasn’t until she began blacking out that she suspected something more serious was wrong. She notes on the day of the crisis she was cold and her blood pressure was extremely low.

KG reports that “a month before the clots my toes on the right side got red and swollen and felt throbbing. After working out at the gym had chest pain, shortness of breath, [my] ribs hurt, heavy chest that felt like extreme gas pains.”

KD describes how the pain seemed to move with the clot. “The pain in my left quad felt like an injury. Then when it moved to the ribs, it felt like I had pulled ribs. Then when it moved to the right side, it felt like a kidney stone and only hurt bad when I was lying flat on my back. My leg pain, after the clot had already exploded into my lungs, was like a bad Charley horse. My lungs had clots everywhere.”

SD reports severe leg pain 3-4 weeks before experiencing the difficulty breathing associated with her PE.

Waxing and Waning Symptoms

For 43 year old DW symptoms like dizziness, blackouts, and vomiting had emerged a week prior and then dissipated until the day of the event, when they returned along with severe shortness of breath, chest pain and heart palpitations. She describes the pain as “tight legs, stabbing pain and then collapsed. All happened within 5 minutes.

For DD the DVT that preceded the pulmonary emboli “felt exactly like a Charley horse. When it lasted more than two days and I started limping, I knew I needed to consult a nurse at the ER.” She too had symptoms that waxed and waned over the month preceding the crisis.

R indicated that she experienced breathing difficulties and chest pain that would wax and wane over the six months prior to her PE diagnosis and that it wasn’t until a few days before the crisis, that it became severe. “On the second night when I tried to sleep, I had severe pain in my upper back and left side of my chest, which started to radiate up to my neck and left shoulder. I experienced more pain in my chest if I tried to inhale deeply.”

Unremitting Fatigue as a Key but Non-Specific Symptom

Uncharacteristic and unremitting fatigue was one of the most consistently reported symptoms across all time points and diagnoses.

LL reports severe fatigue for at a least a month prior to the crisis as the leading symptoms. She notes the fatigue appeared well before the pain. “The fatigue leading up to this was very bad. It was such a struggle to get out of bed or do anything. It was there a good while before the pain.” She also reports restless legs, and “severe stabbing pains in my back” especially when “bending down to pick something up.”

Breathlessness and Speaking Difficulties

As one would anticipate with pulmonary emboli, difficulty breathing was a cardinal symptom of the impending crisis.

Breathing Difficulties

“felt like I had become rapidly, extremely unfit. Could not walk up the stairs in one go. Was struggling to get enough oxygen.”

J believes her symptoms emerged months before the crisis. She reports a “hairball-like cough” for months that was continually diagnosed as allergies. It was persistent and would not respond to allergy medicine. She experienced moderate to severe fatigue for the month leading up to the crisis, along with moderate to severe shortness of breath, irregular heartbeat, heart palpitations, cough, dizziness and nausea.

LT said “chest wall pain two weeks before diagnosis felt like soreness from lifting weights. When the back pain localized to my side and upper back, it felt like I had pulled muscles in those areas. The shortness of breath felt like I was getting out of breath way too easily; walking 30 feet felt like I had been running for half a mile, and slowly climbing the long escalator out of the subway station felt like I was trying to run up the stairs.”

SM experienced severe shortness of breath for at least a month prior to her diagnosis. She says she felt as though “…the middle of my chest was being pressed or squeezed.”

Speaking Difficulties

Many women report difficulty breathing in the months, week and day before the crisis. Speaking, because of the breathing difficulties, becomes increasingly labored.

NB said she would gasp for breath and was “only able to get 1-2 syllables between gasps.” She said she felt like she “had run for her life and just couldn’t catch my breath.”

JZ felt “very winded, even in casual conversations,” but otherwise didn’t report any symptoms.

Conclusion

These and other personal accounts of birth control-induced blood clots suggest that for many women, early signs are present but not recognized. Similarly, blood clots appear to be distributed throughout the body. This is consistent with the fact that hormonal birth control induces systemic changes in hemodynamics. To fully delineate the risks, however, we need more data. If you or someone you know has suffered from a birth control induced blood clot, please consider participating in the study.

We Need Your Help

More people than ever are reading Hormones Matter, a testament to the need for independent voices in health and medicine. We are not funded and accept limited advertising. Unlike many health sites, we don’t force you to purchase a subscription. We believe health information should be open to all. If you read Hormones Matter, like it, please help support it. Contribute now.

Yes, I would like to support Hormones Matter. 

This article was published originally on November, 2016. We subsequently lost funding to finish this study. Nevertheless, we are still accepting stories about birth induced blood clots. If you’d like to share your story, send us a note: Write for us. Other stories and articles about birth control and blood clots can be read here.   

Photo: autopsy of birth control induced pulmonary emboli in a young woman.  

 

I Had a Stroke From Hormonal Birth Control 

3769 views

A little over 2 years ago, on May 31st, I had a stroke caused by my birth control pill, Loryna. I had been on the pill for approximately 9 months before the clots developed. I didn’t even know what a stroke was until I was in the hospital and I kept hearing the word. Here I was 31 years old and in the hospital after suffering from a stroke.  

I was 6 months into a new manager position when the pandemic hit. We closed like everyone else. I worked for 2 days then I was off for the weekend. I woke up that Saturday and my left leg was killing me. I could barely walk, but I still managed to go back to my place of business to see if they needed any help. After work, I did some shopping and then went home because I couldn’t stand the pain anymore. I went to the ER later that day and they gave me an ultrasound. They said they found nothing. NOTHING! They were very dismissive and sent me home. 

The next morning changed my life forever. I woke up and my leg hurt even worse. I called my mom and told her what happened and told her that I wanted to go to a different ER. Things went downhill from there. I passed out and hit my head on my nightstand. By the time I woke up, my mother was there with the EMTs. I know I couldn’t breathe. I had an ischemic stroke and pulmonary embolism. The clot went up my leg, through my lungs, across my heart, and into my brain. I was in the hospital for a week. 

As I said before, I had no idea what a stroke was before this! I kept hearing it when I was in the hospital and they said my birth control, Loryna, caused the stroke. I also found out that I have a clotting disorder. I would think my doctor would have tested me for a clotting disorder before prescribing birth control, but I guess they don’t do that and they don’t tell women about the risks. I didn’t know that my birth control would give me a stroke. Think before you decide to get birth control. The birth control I was taking had low hormones, but I still developed a clot that led to pulmonary embolism and a stroke. 

I learned the hard way that doctors do not take the symptoms of blood clots seriously. I knew something was wrong, but I was sent home from the ER. If you feel like you have developed a blood clot from hormonal birth control and are being pushed away at your doctor’s office or ER, go to another one immediately. It could save your life. 

It has been just a little over two years since my stroke. The stroke affected me in many ways. I have issues with my speech. I had many panic and anxiety attacks that I still suffer from today. I was depressed, lost the best job I have ever had, and my confidence went right out the window. 

My stroke was pretty severe but they said because of my age and how healthy I was overall, I survived. After the stroke, it took a lot of people to convince me that I could do anything, as long as I put my mind to it. My first job was at a beauty supply store and currently, I’m working as a receptionist for a great company. They say in therapy that after you have a stroke, you are always recovering. I find that to be very true.

We Need Your Help

More people than ever are reading Hormones Matter, a testament to the need for independent voices in health and medicine. We are not funded and accept limited advertising. Unlike many health sites, we don’t force you to purchase a subscription. We believe health information should be open to all. If you read Hormones Matter, and like it, please help support it. Contribute now.

Yes, I would like to support Hormones Matter. 

Photo by Marcelo Leal on Unsplash.

Profits Over People: Medication Risk and Drug Company Misconduct

5940 views

If you haven’t read Chandler Marrs’ article on the safety of medications, take a moment to do so and understand that no medication is, as Marrs puts it, “perfectly safe.” I’m here to reaffirm this harsh pill to swallow (pun intended) through the telling of my own experience and the showcasing of research that reveals just how much sway Big Pharma has over the safety of medications.

I was 20 years old when I decided to take my doctor’s advice and go on hormonal birth control to help regulate my periods. I remember my mother, a registered nurse who worked in a local hospital, voicing her concerns about the oral contraceptive. At the time, she was seeing quite a few girls my age come in with clotting complications related to the pill.

Thinking I knew what was best for me, I ignored her advice to stay off of the medication. I was comforted in knowing that almost every single one of my close friends was taking some form of birth control, and they were fine. I’d be fine too.

I couldn’t have been more wrong.

Two months later, I was in the emergency room with a bilateral pulmonary embolism or multiple blood clots in my lungs. What I originally thought was a relatively safe medication turned out to be a life-threatening decision. Suddenly gone forever was my notion that any medications I was prescribed would be taken without risk.

After six months on blood thinners to dissolve the clots, I went back to living my life normally, both clot and birth control-free.

Fast forward four years, and I’m reading news stories discussing the thousands of lawsuits that have been filed against the makers of Xarelto, the same blood thinner I was prescribed to help me recover from my embolism. Although I suffered no complications from the medication, I was clearly one of the lucky ones this time. The anticoagulant, which is still on the market today, has no known antidote to reverse its blood-thinning effects, and it has caused so many severe internal bleeding incidents and deaths that legal action has been taken.

Prior to doing any research, my emergency room experience would have made me cast aside the lawsuits as frivolous. There’s a risk with any medication; I can’t deny that I knew the risks before I opted to take birth control. But, didn’t they also know the risks before agreeing to take the blood thinner just like I did?

Drug Company Misconduct

After digging deeper, I realized there was a bigger issue at hand. Drug companies wield an incredible amount of influence within the healthcare sphere that can lead to the approval of medications that should never find their way into patients’ hands in the first place. A major showcase of this influence is seen in Big Pharma’s ability to fund clinical trials.

These clinical trials must be conducted before a drug is approved for market, and funding has typically come from government sources like the National Institutes of Health. But in recent years, more and more industry-funded clinical trials are taking place, meaning that drug companies can sponsor their own medications studies. Critics of this funding allowance point to the fact that the potential for financial gain can lead to a conflict of interests. Companies that have a vested interest in a drug’s approval because it brings a boost in profits could favor positive outcomes while ignoring any negative results.

In the case of Xarelto’s industry-funded clinical trial, it was discovered that Johnson & Johnson withheld information from the FDA that would have highlighted the blood thinner’s inferiority to its comparison warfarin. During the study, 14,000 patients were given an overdose of the traditional anticoagulant due to the use of a faulty blood-testing device, decidedly skewing the results. The design of the company-sponsored trial also limited the distribution of Xarelto to once-a-day dosing that weakened the medication’s effects on participants. With less severe side effects being observed because of the smaller dose, Xarelto’s clinical trial looked favorable for the new experimental drug.

We see a similar story of clinical trial misconduct being told with another blood-thinning medication, Pradaxa. Pradaxa was put through an industry-funded study whose poor trial design led to FDA approval. Critics point out that there was probable cause for bias since it failed to be a double-blind study. Its trial participants were also made up of a demographic of people who were less likely to be prescribed the medication once it hit the market.

The FDA went on to approve the anticoagulant despite the lack of an antidote, but its decision was based on the fact that Pradaxa “wasn’t inferior” to traditional warfarin. This labeling could bring the drug to market, but it wouldn’t be able to give manufacturer Boehringer Ingelheim a leg up in its promotion of the medication. Therefore, the drug company requested that Pradaxa be labeled as “superior” to warfarin in its ability to reduce strokes so that it could make this claim in its marketing materials. The FDA granted the company’s request, decidedly ignoring its original concerns with the blood thinner.

Pradaxa hit the market without an antidote just like Xarelto, and I bet you can guess what happened next. Thousands of patients taking the medication suffered severe internal bleeding complications and even succumbed to the side effects. Like Johnson & Johnson, Boehringer Ingelheim faced a shocking number of Pradaxa lawsuits and created a $650 million settlement fund in 2014 to satisfy the claims.

Profits Over People

We cannot deny that every medication presented to us comes with some sort of risk to our overall health and well-being. I suffered the risks of birth control but miraculously avoided the complications associated with Xarelto. Costs and benefits are just a fact of the pharmaceutical industry.

But, the issue lies in the influence of Big Pharma. If drug companies, who are so clearly focused on boosting their profit margins, can impact clinical trials in such a way that it costs patients more than it benefits them, where do we draw the line?

It will take massive changes in the drug approval process and overall state of healthcare before we can start to see patient lives being placed above profits. But, what we can do is stay informed and educated on the prescriptions we’re taking. There is a lot going on behind the scenes before a medication makes its way into that little orange pill bottle, and it’s up to us as consumers to do our research, look into the possible complications, and voice any and all concerns with our doctors.

We Need Your Help

More people than ever are reading Hormones Matter, a testament to the need for independent voices in health and medicine. We are not funded and accept limited advertising. Unlike many health sites, we don’t force you to purchase a subscription. We believe health information should be open to all. If you read Hormones Matter, and like it, please help support it. Contribute now.

Yes, I would like to support Hormones Matter.

Image by Thomas Breher from Pixabay.

This article was first published in January 2018. 

Birth Control Induced Pulmonary Embolism While Driving

2242 views

I am a 37 year old woman who has been taking birth control since I was 15 years old and I had a pulmonary embolism (PE) while driving last year. I was on Aviane for over 6 years and then switched to Camrese on 9/19/18 and was taking that up until the PE on 12/13/2018. Before going Aviane, I was on many other generic forms of estrogen type birth control since I was 15 years old. My main reason for taking birth control was to control my cycle. Preventing pregnancy came later on in my adult life.

On December 13th, 2018, I was traveling home from a Tribal Belly Dance Retreat in Hawaii. I was in the best shape of my life and was really enjoying my life to the fullest. While driving from the Phoenix Airport to Flagstaff Arizona, I started to feel tired. I felt like I was going to pass out. The anxiety of that feeling was intense. Within an hour after I started driving, I lost consciousness on Interstate 17 going northbound and then I came to, going 75mph. I lost control of my car and flipped 4 times, continuing to gain and lose consciousness, until the car stopped. I had no idea I was having a pulmonary embolism, until I reached the hospital and they saw something odd in my MRI.

During the crash, I was terrified. I really thought I had gone to hell. After the car stopped rolling, I was alone and could not figure out how to get out of the car. I passed out in fear and then woke up outside of my car, wandering around. At some point, I picked up four tarot cards from the mess of the paperwork and luggage that was thrown from the trunk of my car. I was completely alone in the middle of highway. Luckily my car rolled into a patch of rocks and grass, instead of the area I had just passed, which would have left me in a ditch of one of the multiple cliffs along Interstate 17.

The next thing I know, a truck driver came from out of nowhere and called 911 to get me help. I have not been able to get in touch with that truck driver who saved my life or the ambulance EMT that rode from Sedona to Flagstaff with me and kept my spirits up during the most confusing and scary time of my life. I would really like to thank them for their kindness.

At the hospital, they identified the pulmonary embolism through an MRI. I was shocked and freaked out, to say the least. That night at the hospital, I went into convulsions and had a mini-seizure, which lasted about half a minute. After four days, they released me from the hospital. It was noted that I would be on blood thinners for 6 months. I was not able to return to work until January 21st and only then with a limited work schedule of only 4 hours a day. I just recently returned to work on a normal schedule on February 12th.

This has event has left me with a totaled car, monstrous hospital bills and limited funds to pay for it all due to how long I was out of work. I am also at a loss for words that the mental stress it has caused. I will never be the same but I am thankful that I am alive.

Prior to the pulmonary embolism, I was a casual social smoker, smoking only 1-2 cigarettes every 2 weeks. I have since stopped completely. I was generally healthy but had one issue that my naturopath said was related to the birth control. I developed chronic salivary gland stones and had about 5 of them removed in 2014. My body has produced them since 2005 and all of the doctors I have seen, have never been able to tell me why, except my naturopath, Dr. Brandi Gowey. She said at one point that she thought they were a result of the birth control I was taking and had recommended that I come off the birth control. I obviously did not take that advice. I wish I had.

We Need Your Help

More people than ever are reading Hormones Matter, a testament to the need for independent voices in health and medicine. We are not funded and accept limited advertising. Unlike many health sites, we don’t force you to purchase a subscription. We believe health information should be open to all. If you read Hormones Matter, like it, please help support it. Contribute now.

Yes, I would like to support Hormones Matter.

Photo by Egor Ivlev on Unsplash.

Birth Control Fatalities Show Unexpected Characteristics

2256 views

Over the better part of the last year we have been collecting data about birth control induced blood clots. This work is part of a multi-phased project to determine a more realistic appraisal of clotting risk than those currently marketed by industry. We know that the synthetic hormones used in birth control increase blood coagulation factors by 170% and decrease anti-coagulation factors by at least 20% in all women who use these products. What we do not know is why some women develop clots relatively quickly after commencing with these medications and others can withstand the changes in hemodynamics for years, sometimes decades, before the clots become problematic.

Industry safety pamphlets tell us that clot risk is increased in women over the age of 35 years, who smoke and/or are overweight, suggesting that for everyone else the risk of clotting is minimal. Similarly, there is a recognition that women with known clotting disorders are at increased risk of birth control induced blood clots (though very rarely are these tested before commencing hormonal birth control). Beyond that however, the major medical societies routinely proclaim the safety of these medications for all women, even women with health issues that should logically preclude the use of hormonal birth control, like those with migraines, high blood pressure, and diabetes.

How is it possible that a class of medications known to alter hemostasis and affect over 50 metabolic reactions (Nelson Pill Hearings, pg. 6311) be considered safe for all, or for anyone really? Politics aside (and yes, we are pro-women’s rights, choice and health), it is difficult to reconcile the very real changes in chemistry with any legitimate conversation about safety. The chemistry predicates the clotting, incontrovertibly. Eventually, the alterations in chemistry induced by hormonal contraceptives are bound to create problems. The only questions that remain are when and with what degree of severity?

These are important questions that one should have answers in advance of deciding to use hormonal contraceptives. Indeed, these questions should have been answered decades ago, but they were not, leaving women to make these decisions based more on faith than on facts. Our mandate for this project is to answer those questions. With Phase 1, the pilot study now complete, patterns are emerging, that if confirmed in Phase 2, may flip what we think we know about hormonal birth control and blood clots, upside down. Namely, who gets clots, the over 35 smoker or the otherwise healthy younger woman? And once those clots develop, who is likely to survive them?

What We Found

Contrary to what we expected, the results from our study showed that it was younger, more active women who developed clots in general, but also who subsequently died from those clots. Our sample size was small and these trends may change with the larger sample size anticipated in Phase 2, but for now, our results are in direct conflict with the stated risks. The women who survive blood clots were older, less active, heavier, and had more cumulative health risks than those for whom the clots were fatal. In addition, NuvaRing was proportionately more likely to correspond with blood clot fatalities than any of the other contraceptive methods.

Why younger women were more likely to clot and subsequently die from blood clots is not yet clear. Clotting disorders did not explain this finding. Two variables that may be indicative, include exercise and alcohol use. Overall the younger women were more active and in the deceased group activity levels were significantly higher than in the survivor group. Similarly, alcohol use though low overall, was higher in the deceased group as well. Both of those variables are known to favor clotting dynamics; then again, so too are smoking and obesity and neither of those variables was significant. Similarly, it is also possible that NuvaRing was uniquely involved, either because of the progestin and/or because of the route of administration. Since NuvaRing tends to be favored with younger women it may be a factor in the younger ages of those who perished. With the larger sample size anticipated in Phase 2 of this project, we’ll be able to more fully delineate these risks. For now, the results tell us that what we think we know about hormonal contraceptives and clotting may require re-evaluation. Described below are the study details.

Birth Control and Blood Clots Pilot Study Results

General Information

Phase 1 of the research involved collecting survey data and case reports from women who have suffered from blood clots while using hormonal birth control and from family members of women who died from birth control induced blood clots. The survey was advertised via social media and respondents completed the survey online. Case histories were collected online and included phone interviews. The final sample included 87 completed surveys, including 77 self-reports and 10 surveys completed by a family member of a deceased woman. This was from a larger pool of 125 partially completed surveys. Case histories were collected from 26 women or families and continue to be collected as part of the second phase of the project.

Demographics

  • Average age at diagnosis of blood clot: 31 years (range: 15-52)
  • Average duration of birth control usage at time of clot: 8.52 years
  • Race/ethnicity of respondents: 90% Caucasian

Type of Event: Primary Diagnosis

  • Pulmonary Embolism (PE): 33%
  • Deep Vein Thromboembolism (DVT): 19%
  • PE plus DVT: 16%
  • Stroke: 44%
  • Peripheral Artery Disease: 3%

Which Contraceptives Are More Dangerous?

While the small sample size and the possibility of an availability bias in participant recruitment precludes answering this question with confidence, the early trends suggest that the NuvaRing and the drosperinone-based oral contraceptives may pose a higher risk for thrombotic events and NuvaRing may pose a higher risk for fatality. Notably, a significantly higher proportion of the women who died from blood clots were using NuvaRing at the time of their clot than those who survived, 66.7% versus 19.2%, respectively [ X2(2, N=87) =9.985, p = .007]. As the sample size increases in Phase 2 of this project, these data may change and results will become clearer.

  • NuvaRing (etonogestrel) -21
  • Drospirenone based oral contraceptive (Yaz, Yasmin, Ocella) – 15
  • Levonorgestrel based oral contraceptive (LevLen, Seasonale, Amethia, Lovara, Microgynon, Camrese) -12
  • Norethidrone base oral contraceptive (Loestrin, Microestrin, Gildess, Estrostep, norethindrone, micronor) – 15
  • Norgestimate based oral contraceptive (OrthoTriCyclen) – 10
  • Desogestrel based oral contraceptive (Marvelon, Viorele, Mircette) – 7
  • Cytoproterone based oral contraceptive (Dianette, Diane) – 4
  • DepoProvera shot – 3

Risk for Clotting: Stated Versus Actual

We know from the chemistry that all hormonal contraceptives induce system-wide changes in hemodynamics. From this standpoint, one would expect that all women who use these medications would develop clotting issues at some point, that longer duration increases risk, higher dosages induce clotting more quickly, and additional health risks expedite the time frame to clotting event. These trends have not been born out with any consistency in the decades since the associations were first observed, suggesting that how we look at the risk factors for clotting may be incomplete or incorrect. Some of our preliminary data suggest that the marketed risk factors are not as clearly impactful, from a population standpoint, as expected. That is, the commonly stated risk factors occurred in very small percentage of the test sample suggesting that other, yet to be identified variables may contribute more heavily to risks.

All contraceptive risk labeling includes four primary risk factors: genetic clotting disorders, obesity, smoking, and age. Absent those risk factors, contraceptives are marketed as safe.

Genetic Clotting Disorders

  • Only 9% of the total sample had a clotting disorder, all identified after developing a clot and there was no significant difference in the proportion of women with clotting disorders between the groups.

Obesity

Obesity was measured using the body mass index (BMI) calculation. A BMI of greater than 25 is considered overweight and one greater than 30 is considered obese. It should be noted, however, that BMI calculation, though a standard measure, has several limitations including overestimating obesity status in athletic, highly muscular women. Overall, the women tended to be overweight, but not obese, with a large variability in weight across the sample.

  • The average BMI for the sample was 28.33, SD=7.6
  • There was no statistical difference in BMI between the women who survived and those who did not, although the average BMI of the women who died tended to be lower (M=25.27, SD = 2.6) than those who survived (M=28.8, SD =.87).

Smoking

  • Only 17% of the study sample had ever been smokers
  • Only 8% of the women were smokers at time of their clot crisis
  • 75% had never been smokers
  • There was no statistically significant difference between the proportion of women who smoked, developed blood clots, and survived, and those who did not.

Age

  • Risk literature emphasizes that women over 35 are at greatest risk; however, in our survey population the average age of women at the time of their blood clots was 31 years; nearly 70% of the women who developed clots were under the age of 35.
  • Women who died from blood clots were significantly younger (M=24.78 years, SD =5.80) than those who survived [(M=32.5 years, SD =8.9), t(65)= 2.518, p=.014]. This is in direct opposition to what would be expected e.g. that older women would have a reduced likelihood of survival. With a larger sample size, this trend may change.

Contributing Lifestyle Variables

Long periods of sitting as would occur with extended travel is a known risk for clotting, across all populations. Early researchers noted that exercise naturally increased clotting factors and recent research suggests that alcohol use also increases the propensity to clot (in men). Additionally, one might expect the use of other medications would impact clotting and survival. As part of the pilot study, we assessed those risks to see if these variables were contributing factors.

Travel

  • 6% of the women reported extended travel in the three months leading up to their blood clots.

Exercise and Activity Level

Survey respondents rated their activity level based upon the following scale. Over half of the total respondents were somewhat to very active.

  • Completely inactive – 1%
  • Not very active – rarely exercise -40%
  • Somewhat active – moderate or vigorous intensity exercise 150 minutes per week – 34%
  • Active – moderate or vigorous intensity exercise 300 minutes per week – 22%
  • Very active or athlete- intense physical exercise 6-10 hours per week – 2.35%

When we compared the activity levels of the women who died versus those who survived another striking pattern emerged. The women who died (M= 2.5, SD =.93) were significantly more active than those who survived (M=1.78, SD =.84), [F 1, 83) = 5.274, p =.024].

Alcohol Intake

Respondents were asked several questions about alcohol intake over the three months preceding the clots. These included average days per month that alcohol was consumed, average number of drinks per day, and maximum drinks in any one 24-hour period. While alcohol consumption was relatively low over all, there was a significant difference in the number of drinks per day between women who died versus those who survived. The deceased group drank an average of 2.11 drinks per day (SD =.46), while the survivors group consumed only .65 drinks per day (SD = .11), [t(85)=4.056, p=.000].

Medication Use

A number of medications increase clotting while others may increase bleeding. How most medications interact with each other and with hormonal birth control to influence clotting is unknown. Delineating those interactions is important for women. The small sample size in the pilot study prevents us from addressing individual medication interactions. Nevertheless, we decided to assess the overall trend in medication use and propensity to clot; more specifically, whether the use of fewer medications would contribute to survivability. What we found was surprising. A significantly smaller proportion of women who died (33%) versus those who lived (67%) were using additional over-the-counter and/or prescription medication [X2(2, N=87) =10.233, p = .006].

Combined Risks

While we cannot yet determine what combination of risks predict clotting overall, we ran some preliminary analyses to see if an accumulated number of lifestyle factors increase or decrease the survivability of clots. Unexpectedly, the women with fatal blood clots had a non-significantly lower number of accumulated risks (M=3) than those who survived (M=4). The limitations of this study preclude any definitive conclusions, but this trend could indicate either that how we tabulate risk is incorrect and/or that it is simply and solely the hormonal contraception that increases the risk.

Time to Clot

One of the pervading myths surrounding birth control induced blood clots is that they develop early on. The suggestion is that if one makes it through so many months or years without clotting, clotting is unlikely. This is partly because of the substantially increased risk of thrombosis in women with genetic clotting disorders and the assumption that those events will develop at the onset of hormonal contraceptive use. We cannot yet answer the question of whether those with clotting disorders develop clots more quickly compared to women without (the numbers are still too small, only 9% of our sample reported a genetic clotting disorder). However, we can say that most women in our study developed clots after at least a year of use.

  • 75% of the women developed clots after a year or more of use

Early Warning Signs

Blood clots are notoriously difficult to diagnose as the symptoms often correspond with a myriad of other non-specific health issues. One of our goals for the entire study will be to determine early warning signs. To that end, we asked the respondents to rate the presence/absence and severity of 35 common symptoms of blood clots a month before, a week before, the day before, and the day of the crisis. Although we found significant linear trends in the escalating severity of many symptoms across time for the group as a whole, more telling were the patterns that emerged when we divided the groups by diagnosis (DVT,  DVT + PE, stroke, etc.). There we saw distinct patterns in the type of symptoms as well as the trajectory of expression and severity.

As we reported previously, when we looked at the patterns of early warning signs of pulmonary emboli, we see two, possibly three, trends emerging. In some women, pulmonary emboli seem to appear suddenly with few if any warning signs. In other women, symptoms either increased over time or waxed and waned (or both), sometimes for months (as reported in the comments section), until reaching an apex of severity. For the latter group, the waxing and waning seemed related to the movement of the clot(s) from the periphery to the lungs. That is, the localized pain, swelling, and temperature changes, either in the legs, pelvis, abdomen, or collarbone regions, would be severe for a week or a month before the event and then dissipate entirely, only to re-emerge as the crushing pain associated with the pulmonary embolism. We will be reporting more details in subsequent articles, but preliminarily, the data and the personal accounts suggest the possibility that PEs may be preventable, if the signs of deep vein thrombosis (DVT) are more readily recognized.  With the larger sample size in Phase 2, we may be able to delineate these trends more fully.

Medical Inattention and Dismissal

Among the more disturbing findings was the complete disregard for even the most basic but well-known contraindications when prescribing these medications (age, smoking, and family history of clotting). Also troubling was the dismissal of symptoms by medical professionals once the crisis became imminent.

Ignored Contraindications

If clotting disorders, age and smoking are known risk factors, we would expect those risks to be identified prior to the prescription and in some cases, prevent the use of these medications entirely. This does not appear to be the case.

  • Only 1% of women were tested for clotting disorders prior to receiving the prescription, even when they reported a family history of clotting disorders.
  • 33% of our sample were over the age of 35 at the time of their blood clot crisis; 19% were over the age of 40 and the oldest was 52 years of age at the time of the clot – well past the age when hormonal contraceptives should be used.
  • 8% of the sample population were smokers, smoking is reported as contraindication for hormonal contraceptive use.

Medical Dismissal

A review of the case stories and the comments sections within the survey reveal that a good percentage of women recognized something was wrong, sought medical attention, but were dismissed and sent home, sometimes repeatedly and sometimes over a period of weeks and months. It was often not until arriving via ambulance that the severity of the situation became apparent. Even then, the case stories suggest that the physicians seemed to place the possibility of a birth control induced clot low on the diagnostic differential. Blood clots must be ruled in, rather than ruled out. This is something that has to change.

Final Thoughts

These results, while preliminary, show striking trends; namely that younger, more athletic women may be at a higher risk for clotting and clotting fatalities. To fully delineate and validate these trends we will need more data. If you or someone you know has suffered from a birth control induced blood clot, please encourage them to participate in Phase 2 of our study.

We Need Your Help

More people than ever are reading Hormones Matter, a testament to the need for independent voices in health and medicine. We are not funded and accept limited advertising. Unlike many health sites, we don’t force you to purchase a subscription. We believe health information should be open to all. If you read Hormones Matter, like it, please help support it. Contribute now.

Yes, I would like to support Hormones Matter. 

Pulmonary Embolism after Four Months on the Pill

2075 views

I was a sophomore in college when my life changed. I was an active college student who enjoyed going to the gym. One night I was at the gym on the stair climber and something did not feel right. I got off and all of a sudden blacked out. My heart was racing, my chest was tight and I was very scared. I went back to my dorm to try to sleep it off, but I had a hard time falling asleep.

The next morning I tried walking to class, but once I stepped outside I could not breathe. Going to school at the University of Nevada, Reno it was snowing and cold, so I thought I couldn’t breathe because of the chill. Shortly after, I called my mom and she insisted I go to the campus health center. I went and they did a bunch of tests. Finally, the doctors decided to do a blood test. If those results came back positive, I would have to be rushed to the ER.

Sure enough, I had a positive result. I had multiple pulmonary embolisms. I was hospitalized for three days and given many different anticoagulants (blood thinners) to get my levels back to normal.

After this happened, I was scared for a very long time. It took me a while before I could get back on the stair climber at the gym due to the event. Luckily, I am all healthy now. I take a baby aspirin in the morning to prevent any clotting. I am lucky to be alive and I am very thankful for that.

Symptoms Leading up to the Pulmonary Embolism

Looking back, I had some chest pain during the week, but I figured my symptoms were from the cold I had. It was not until I was on the stair climber, working out vigorously and passed out that I thought something was wrong.

Prior to that, I was not taking any other medications, just the birth control. The pill I was on is called Trivora. I was in overall good health.

I started birth control in August of 2013 and I had my PE on December 2, 2013. I was only the pill for 4 months. I took it religiously, every day at the same, for the four months I was on it.

After I was hospitalized, I had to go to a Coumadin clinic to test my blood every week. I also had to see a cardiologist and get an echocardiogram to make sure that my heart was okay with all the Coumadin that I was taking. Luckily, everything came back negative.

The doctors did test me for clotting factors and heredity tests to see if it ran in my family. I was the only woman on birth control in my family. Luckily, those tests came back negative too.

To this day, I continue to work out regularly and listen to my body if I feel something is not right. The biggest aspect that saved my life was going to the doctor. I know many people are afraid of doctors or worried that they will hear bad news, but it can save your life. I tell all my friends who are on birth control that if they feel not right or something is off with their body to seek medical attention right away.

I hope what I experienced never happens to anyone else. It was the scariest experience of my life and I count my lucky stars every day to be alive.

Real Risk Study: Birth Control and Blood Clots

Lucine Health Sciences and Hormones Matter are conducting research to investigate the relationship between hormonal birth control and blood clots. If you or a loved one have suffered from a blood clot while using hormonal birth control, please consider participating. We are also looking for participants who have been using hormonal birth control for at least one year and have NOT had a blood clot, as well as women who have NEVER used hormonal birth control. For more information or to participate, click here.

Julia’s Story: NuvaRing Induced Disseminated Intravascular Coagulation

2402 views

Julia Ruth West Ross (1983-2013)

Julia, our middle daughter, lived in Southern California while earning an M.A. in Economics at UC Irvine. She enjoyed Southern California because there was so much she liked to do there.  She loved camping, beach trips, Mexican food, music concerts, hanging out with friends, beer tasting, and her two cats.  She started working at her first professional job in 2011 and she then met her husband Eric. Julia and Eric had just married and were so excited to be in their new apartment and all of us were so happy for them. It was a wonderful time.

Julia called me on Tuesday night on her way home from work. She was looking forward to the upcoming weekend as she was getting things packed for their delayed honeymoon cruise that coming Sunday. She was so happy.

Eric and Julia were married for just under five weeks when I got a call two days later from Eric that Julia was in the Emergency Room.

Early Signs of NuvaRing Clotting

Eric told me that Julia had been feeling tired for a few days, but that on Wednesday night, as she walked to her car after work, she felt faint, had tunnel vision and was short of breath. She got home and climbed into bed early. Usually full of energy, this was not like Julia, and Eric was surprised when he came home from work to find the house dark and Julia in bed. She told him she felt really tired and nauseous. He later told us that night “she threw up once or twice but it was mostly just dry heaving with just a little bit of liquid, the liquid though was very dark. Also, she had not eaten very much the last few days. I don’t remember the exact details but I think she had hardly eaten the day before and may not have really eaten that day either. If she did eat, it was a very small amount.” She also had diarrhea.

Thursday morning, thinking she had the flu; Julia stayed home from work, another unusual thing for her. Later that morning she called Eric, asking him to take her to an Urgent Care. She was feeling worse. She couldn’t breathe, felt very weak and faint. Eric rushed home and took her to Urgent Care.

At Urgent Care they saw she was in respiratory distress. Her blood pressure was low and her heart was racing. As they were preparing to intubate her, she fainted. They completed the procedure and transported her to the Emergency Room. We read later in her medical records that she told them she felt “a sense of impending doom,” and we also read that the ER doctor removed a NuvaRing.

Eric called again much later that Thursday night to tell us the doctors wanted to put Julia in the ICU and asked him if her parents knew. He also told us that the doctor said her kidneys weren’t functioning and they wanted to put her on dialysis. This was more than a standard emergency room visit. The ICU? Kidneys not functioning? Dialysis? Do her parents know? We didn’t know what to think. Alarmed, worried, and not understanding what was happening, my husband and I flew the 450 miles to be with Julia.

We arrived at the hospital on Friday morning, and saw Julia briefly. She was sedated, so she didn’t know we were there. The nurse sent us to the waiting room because she needed to do some things in the room. Waiting seemed to take forever.

Sepsis or Missed Pulmonary Emboli?

An hour later the ICU doctor came to tell us that they thought Julia had septic shock and they had put her on a sepsis protocol, giving her antibiotics and antifungals to treat any infection. They also had her on vasopressors to help increase her blood pressure. They were also trying to get a dialysis machine set up.

The ICU doctor assured us that Julia would recover, saying, “Julia is young and strong.” The doctor seemed very confident as she explained that Julia would be in the ICU for a few days and moved to another floor to recover for a week or more. The doctor sounded so sure of herself.  We were still anxious and just wanted to be with our daughter. Her dad and I again were allowed to see Julia briefly although we were told again that we needed to wait in the waiting room as they were setting up equipment. We waited with Eric, his parents and sister. We cancelled the cruise trip, thinking it was just a postponement until Julia got better.

An hour later, a nurse ran into the waiting room, yelling, “West family, we need you NOW!” and rushed us down the hall to Julia’s room. The ICU team was frantically doing CPR on Julia. Shocked, we huddled together in the doorway, clutching each other, as we watched the medical team frantically work on Julia.

The ICU team stabilized Julia and we all breathed a sigh of relief and moved out into the hall. Calm was restored to the room and the staff began drifting off to other tasks. Julia went into cardiac arrest again. Again we watched the team rush to perform CPR. We stood outside a set of large sliding glass doors to Julia’s room, with disbelief and increasing dread until Julia’s heart was again stabilized. Calm lasted for what seemed like minutes. Again and again Julia went into cardiac arrest, one after another for over four hours. The ICU team kept up their heroic lifesaving efforts to resuscitate and stabilize her.

One of the doctors on the team told us that we’d have to make a decision at the end of the next hour as to whether to continue resuscitation. We’d been in the hallway for hours and we were told that Julia’s chance of being severely brain damaged was 95% because her blood was so very thin and she’d had so little oxygen to her brain. At the end of that last hour, we reluctantly and painfully told them to stop. We felt we had no option but to let her go. We believe Julia wouldn’t have wanted to live a diminished life, even if they could have saved her. The staff stopped their efforts and left the room for us to gather around Julia’s bed. Within ten minutes of stopping CPR, she was gone.

Asking Why

We left the hospital profoundly shattered and in shock. We had been told that she had septic shock, but we couldn’t understand how that led to her death. We wanted to know what had happened to our wonderful daughter. We requested an autopsy, as did the hospital. We also ordered Julia’s hospital records.

Later, my husband and I flew home. Julia’s husband, her sisters and brother were as devastated as we were.

The autopsy report stated that Julia died from massive bilateral pulmonary embolisms. The autopsy also showed she had a deep vein thrombosis (DVT) in her left leg. The blood clots in her lungs were so massive that no amount of resuscitation could have brought her back due to the massive clots blocking her lungs.

None of this made sense to us. Only the month previous, Julia had a health check up through her employer that showed she was healthy. Her blood pressure was normal, as was her cholesterol.

We wanted to know why our daughter developed pulmonary embolisms and a DVT.  We discovered Julia was using the NuvaRing. We didn’t even know what a NuvaRing was. Our youngest daughter told us that she’d heard of women getting blood clots while on NuvaRing, so we began reading about the increased risk of blood clots for women on estrogen based birth control.

The ICU doctor told us that Julia had septic shock. We knew nothing about sepsis or septic shock. We wanted answers to everything, so we contacted the ICU doctor who had treated Julia and began asking questions, lots of them.

NuvaRing Induced Disseminated Intravascular Coagulation

We learned that Julia had been treated for a condition called Disseminated Intravascular Coagulation (DIC), a process characterized by the widespread activation of the blood-clotting cascade. We had to educate ourselves about DIC and found that DIC is caused by an underlying condition. The increased clotting in DIC uses up platelets and clotting factors in the blood. DIC can cause very small clots to form throughout the body’s small blood vessels. These small blood clots can reduce or block blood flow through the blood vessels, which can damage the body’s organs.  When platelets are used up, the body isn’t able to stop bleeding, as the blood is thin due to lack of platelets. Had tiny clots formed in the small blood vessels in Julia’s body? Was this why Julia’s kidneys stopped working efficiently?

In reviewing the hospital records, we noticed that the hospital had done a CT scan of her abdomen, but they only did x-rays of her chest. We learned that clots do not show up on x-ray. A chest x-ray can find other diseases, such as pneumonia or fluid in the lungs but not blood clots.

The hospital had not done an ultrasound on Julia’s legs to look for a DVT, but leg pain or soreness was not one of Julia’s symptoms. We also looked for lab results for infection that might have caused sepsis or septic shock, but the lab records didn’t show any positive results for anything they tested for.

Julia had not complained of all the typical symptoms that you read about for a DVT or a pulmonary embolism.  We learned that many people do not have the classic symptoms.

At that first phone call with the ICU doctor, after she reviewed the autopsy report, she told us they had not known Julia had pulmonary embolisms when she went into cardiac arrest.

NuvaRing and Julia’s Death

We asked the ICU doctor if the NuvaRing had anything to do with the pulmonary embolism. This doctor, who worked so hard to save Julia, was not familiar with the NuvaRing birth control and suggested we go to the company website for information. Her suggestion made me realize that she really didn’t know much at all about the NuvaRing. She told us that none of the lab tests had shown a cause for the sepsis. She also told us that the hospital would do a formal review of Julia’s case with a team of doctors, including those who had worked on Julia. The doctor couldn’t say more until after the formal review.

The hospital team eventually reviewed everything that happened to Julia, from her admission, treatment, and to her death. We spoke to the ICU doctor again after the review, and she told us she “did a lot of reading, a lot of research on the NuvaRing and strongly felt it had been a component in Julia developing such a massive pulmonary embolism.” She also explained that “a pulmonary embolism might have been brewing,” but that because Julia’s blood developed DIC her blood had become so thin that trying to surgically treat a pulmonary embolism would have caused her to bleed to death, and they couldn’t even give her anticoagulation treatment for the clot.

More importantly as to the cause of death, the ICU doctor told us,

We do not see someone as young and healthy as Julia develop such massive pulmonary embolisms unless there is an underlying factor… and that is hormonal birth control.

The ICU doctor said she and other doctors on the team,

Personally believe the NuvaRing caused Julia’s blood to clot and develop DIC as quickly and as much as it did.

This doctor went on to say:

In young patients like her, any time we see someone pass away from a massive PE like she did, it has never been just from an infection, never been just from sepsis.

It’s always been because of some underlying pathology that has caused the blood to clot the way that it does. Usually it’s an oral contraceptive pill, that’s 90% of the time, and 10% of the time it’s because there’s a genetic predisposition that went undetected or no one in the family had had that problem before. And we didn’t find out until much later.

Julia had been using NuvaRing for two years.

We believe the hospital staff did everything they knew how to do at the time. We truly thank them for all their efforts. But we also believe that they did not connect the dots about a pulmonary embolism forming or that hormonal birth control was causing the clotting that led to Julia’s death.

Our family will never be the same. Julia, our cherished daughter, sister and wife, was young, healthy, loving, vibrant and bright. She had a whole lifetime ahead of her. Julia had confidently used NuvaRing, a combination hormonal birth control, because it had been prescribed confidently to her. We share Julia’s story with our deepest hope that this won’t ever happen to any woman you love.

Dru and Joe West

Laura West, Marc Fish, Nancy Martin and Eric Ross

Photo: Julia pictured with her dad on the day of her wedding. 

Real Risk Study: Birth Control and Blood Clots

Lucine Health Sciences and Hormones Matter are conducting research to investigate the relationship between hormonal birth control and blood clots. If you or a loved one have suffered from a blood clot while using hormonal birth control, please consider participating. We are also looking for participants who have been using hormonal birth control for at least one year and have NOT had a blood clot, as well as women who have NEVER used hormonal birth control. For more information or to participate, click here.

Blood Clots: What Women Know Versus What We Should Know

2903 views

I was on the birth control pill for ten years. I knew that it could cause blood clots in women over 35 who smoked. I wasn’t over 35 and I didn’t smoke. That was all I thought I needed to know. Then I had a stroke. It was caused by the pill and a genetic clotting disorder I never knew I had. In fact, I didn’t know there was such a thing as clotting disorders or that I could have one or that in combination with hormonal birth control, it could kill me. And I certainly had no idea what the symptoms of a blood clot were.

What Do We Know? Not Too Much, It Appears

When I began to do research for my thesis, I wanted to know if it was just me or if other women who took the pill were also unaware of clotting disorders and of the symptoms of a blood clot. Spoiler: I wasn’t alone in my ignorance.

I surveyed over 300 women who had taken birth control pills. Among other things, I wanted to know:

  • What did women know about the risks associated with the pill?
  • Were they aware of clotting disorders?
  • Did they know the symptoms of a blood clot?

Survey Results

Neither Women Nor Their Doctors Understand Risks for Blood Clots

The results of the survey showed that women do not clearly understand the risks involved with taking birth control pills. Many of them believe that certain risks are only associated with being over 35 years of age and/or smoking. This is not surprising given that only a little over half said their doctor discussed the risks with them before giving them a prescription. And for a majority of the women, their doctor never discussed other birth control options with them.

Most of the women were asked about their family history before being given a prescription, but fewer than half of their doctors actually discussed it with them, and fewer than a third of the women actually read the risk information that accompanies their prescriptions. That’s not surprising given how dense and misleading the pharmaceutical companies have made risk communication.

When asked whether they were familiar with the symptoms of a blood clot, most women (60.5%) admitted that they were not. Eight women responded that they had learned the symptoms because a family member or friend had a blood clot, and two participants said they had actually had blood clots. One stated, “When I experienced chest pain and did research online. It turned out that I had pulmonary embolisms (while on BCP- birth control pills).” Only 6 out of 311 women reported learning about the symptoms of blood clots from their doctor. Ironically, more women knew someone who had a clot.

At the end of the survey, the participants were invited to share anything further about their experience on the pill. Here are some of their answers:

My experience on birth control pills, the Nuvaring, or Depo-Provera all proved to be horrendous… I think birth control pills came straight from hell and I hate, hate, hate it. I would rather undergo Chinese water torture daily thank take birth control, and that is the God’s honest truth… My fertility has been affected forever by my under informed choice to go on birth control, and by the irresponsible doctors who encouraged me to switch methods rapidly “until I found what worked for me.”

 

I’ve had two different GYNs give me completely contradictory information about the side effects and dangers of BCPs… Overall, I’m surprised at how little doctors seem to know about female BCP- I haven’t experienced this amount of ambiguity with any other medical specialty or problem.

 

I was shocked- and grateful- when I finally found a doctor who discussed alternatives with me, suggested a wide variety of reading, and let me do my own research and make my own decision before wiring[sic] a prescription. After doing the reading, there is no way I will ever take another birth control pill in my life. Every other doctor I had acted like it was giving out Altoids…

 

I think they’re too often the first option doctors prescribe for reasons other than birth control. That’s frustrating. They’re not a magic pill and some doctors seem to think they are.

The bottom line is that most women do not fully understand the risks involved with taking birth control pills and they are not familiar with the symptoms of a blood clot.

At my thesis defense, when I mentioned that most women (over 60%) did not know the symptoms of a blood clot, my advisor asked, “Well, I don’t think that’s so unusual. Do you think most people know what the symptoms of a blood clot are?”

“No, but I think people who have been prescribed a medication that greatly increases their risk of blood clots should be informed of the symptoms,” I responded.

Who Is Responsible?

This is a simple question with a complicated answer. Who is responsible for making sure women who use hormonal contraceptives, especially women who are at a much higher risk for blood clots, understand the symptoms and when to get help? Is it the responsibility of the doctor who prescribed the medication? Or is it the responsibility of the pharmaceutical company to provide clearer information? Or is it the responsibility of the patient?

From my personal experience, I now know that I cannot trust my doctor to always make the right diagnosis and provide the right treatment. Most of their information comes from the pharmaceutical industry who have clearly demonstrated that they put profit first. And our research is showing that their information is not correct. Therefore, I cannot rely on the drug companies to make sure they provide me with accurate and straightforward information about their medications.

So that leaves me. And you. Until we demand a system that puts patients first, a system of health and transparency, we have to put ourselves firsts. How? We do that by listening to our bodies, doing the research, and learning to trust our intuition. That may mean we have to disagree with our doctors. That may mean we have to ask for a second opinion. That may mean we have to insist on being heard. We can’t be afraid of offending someone or “rocking the boat.” We can’t be afraid of being considered hysterical or melodramatic. We can no longer sit back and hope others are making the best decisions for us. We have to educate ourselves. We must be our own advocates. Our lives depend on it.

And we can start by learning the symptoms of a blood clot.

What Are the Symptoms of Blood Clots?

 Blood clot in leg:

  • swelling
  • pain
  • tenderness
  • an unusually warm sensation in the affected area
  • an unusually cold sensation in the affected area (this is per our research, more details to follow)
  • pain in your calf when you stretch your toes upward
  • a pale or bluish discoloration

Blood clot in chest:

  • sudden shortness of breath that can’t be explained by exercise
  • chest pain, may feel like extreme heart burn
  • palpitations, or rapid heart rate
  • breathing problems
  • coughing up blood
  • dizziness (per our research)
  • uncharacteristic fatigue (per our research)

Blood clot in the brain:

  • severe headache
  • loss of speech
  • numbness or tingling of limbs
  • difficulty seeing or changes in vision
  • difficulty speaking or finding words

For more information about blood clots, especially in conjunction with hormonal contraceptive use, click here.